CHICAGO (AP) — A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment